Search for: "Johnson Controls, Inc." Results 541 - 560 of 1,052
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2014, 11:41 am by Yaron Dori
Inc.; George Salem, Senior Product Manager at Google Inc.; and Craig Spiezle, Executive Director, Founder, and President of the Online Trust Alliance. [read post]
16 May 2014, 8:58 am
 This follows relatively hot on the heels of Rovi’s prior defeat in Starsight Telecast Inc & Anor v Virgin Media Ltd & Ors [2014] EWHC 828 (Pat) (26 March 2014)) [see here, and PatLit's commentary here]. [read post]
25 Apr 2014, 4:06 pm
The dispute first arose when Belafonte made plans to auction off the documents to the highest bidder at Sotheby's, Inc. [read post]
Another company, Turnstyle Solutions Inc., has placed sensors around Toronto that surreptitiously record signals emitted by WiFi-enabled devices and can track users' movements. [read post]
14 Feb 2014, 10:01 am
Danek Med., Inc., 168 F.3d 253 (5th Cir. 1999). [read post]
9 Feb 2014, 2:27 pm
’  The classic action of passing off is based on the trinity of (i) goodwill, (ii) misrepresentation to the public, and (iii) damage to the claimant, as was reaffirmed in the 'Jif Lemon' case (Reckitt & Colman Ltd v Borden Inc [1990] UKHL 12). [read post]
26 Dec 2013, 8:45 am by Joy Waltemath
The court reviewed much of the relevant caselaw, including the Supreme Court’s decision in Automobile Workers v Johnson Controls, Inc, which was central to the case. [read post]
25 Nov 2013, 7:02 am by Juan Antúnez
See Craft; Johnson; see also Estate of Sheets v. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
Allegations Include Off-label Marketing and Kickbacks to Doctors and Pharmacists\Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the… [read post]
4 Nov 2013, 3:04 am by Ben Vernia
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
29 Oct 2013, 7:27 am
Draeger Safety Diagnostics, Inc., C.A. [read post]